Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study.
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231218216. doi: 10.1177/10760296231218216.
Clin Appl Thromb Hemost. 2023.
PMID: 38073058
Free PMC article.
Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
Al Sulaiman K, Aljuhani O, Badreldin HA, Korayem GB, Alenazi AA, Alharbi AH, Alghamdi A, Alhubaishi A, Altebainawi AF, Bosaeed M, Alotaibi R, Alawad A, Alnajjar N, Saleh KB, Sait WA, Alsohimi S, Alanizy MM, Almuqbil SA, Al Sulaihim I, Vishwakarma R, Alalawi M, Alhassan F, Alghnam S.
Al Sulaiman K, et al. Among authors: al sulaihim i.
BMC Infect Dis. 2023 Feb 22;23(1):103. doi: 10.1186/s12879-023-08072-8.
BMC Infect Dis. 2023.
PMID: 36814218
Free PMC article.
No abstract available.
Item in Clipboard
The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study.
Al Sulaiman K, Aljuhani O, Badreldin HA, Korayem GB, Alenazi AA, Alharbi AH, Alghamdi A, Alhubaishi A, Altebainawi AF, Bosaeed M, Alotaibi R, Alawad A, Alnajjar N, Bin Saleh K, Sait WA, Alsohimi S, Alanizy MM, Almuqbil SA, Al Sulaihim I, Vishwakarma R, Alalawi M, Alhassan F, Alghnam S.
Al Sulaiman K, et al. Among authors: al sulaihim i.
BMC Infect Dis. 2023 Feb 6;23(1):75. doi: 10.1186/s12879-023-08010-8.
BMC Infect Dis. 2023.
PMID: 36747136
Free PMC article.
Item in Clipboard
The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study.
Al Sulaiman K, Aljuhani O, Alhammad AM, Al Aamer K, Alshehri S, Alhuwahmel A, Kharbosh A, Alshehri A, Alshareef H, Al Sulaihim I, Alghamdi A, Al Harbi S, Vishwakarma R, Alabdan N, Alrajhi Y, Al Katheri A, Alenazi AA, Alalawi M, Al Ghamdi G.
Al Sulaiman K, et al. Among authors: al sulaihim i.
Saudi Pharm J. 2022 Dec;30(12):1748-1754. doi: 10.1016/j.jsps.2022.10.003. Epub 2022 Oct 8.
Saudi Pharm J. 2022.
PMID: 36601502
Free PMC article.
Item in Clipboard
The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study.
Al Sulaiman K, Aljuhani O, Korayem GB, Altebainawi AF, Al Harbi S, Al Shaya A, Badreldin HA, Kensara R, Alharthi AF, Alghamdi J, Alawad A, Alotaibi R, Kharbosh A, Al Muqati H, Alhuwahmel A, Almusallam M, Albarrak G, Al Sulaihim I, Alanazi B, Al-Dosari BS, Vishwakarma R, Alsaeedi AS, Al Ghamdi G, Alkofide H, Al-Dorzi HM.
Al Sulaiman K, et al. Among authors: al sulaihim i.
Front Public Health. 2022 Aug 11;10:877944. doi: 10.3389/fpubh.2022.877944. eCollection 2022.
Front Public Health. 2022.
PMID: 36033795
Free PMC article.
Item in Clipboard
Cite
Cite